Mark Hamann | Toxicology | Best Researcher Award

Prof. Dr. Mark Hamann | Toxicology | Best Researcher Award

MUSC& Oxford Laboratories | United States

Dr. Mark T. Hamann is a distinguished scientist in drug discovery and biomedical sciences, holding the Charles and Carol Cooper/SmartState Endowed Chair at the Medical University of South Carolina (MUSC). With over 330 peer-reviewed publications and an h-index of 71, he ranks in the top 1% of scientists worldwide. His research focuses on marine natural products, drug discovery, and biomedical informatics, contributing significantly to cancer therapeutics, infectious diseases, and neurodegenerative disorders.

Profile

Google Scholar

ORCID

Scopus

Strengths for the Awards

  1. Outstanding Research Metrics
    • h-index: 71 (Indicates a high impact and influence in the research community).
    • i10-index: 200 (Signifies a significant number of highly cited papers).
    • Citations: Over 18,100 (Reflects global recognition and influence).
    • ResearchGate Score: Higher than 99% of RG readers.
    • Stanford-PLOS One Report Ranking: Top 1% of scientists worldwide.
  2. Extensive Publication Record
    • 330+ peer-reviewed publications and book chapters.
    • Published in prestigious journals like Chemical Reviews, Journal of Natural Products, Molecular Oncology, and Scientific Reports.
    • Frequent first and corresponding authorship roles.
  3. Leadership in Research and Academia
    • Endowed Chair Professor at the Medical University of South Carolina.
    • Holds multiple academic appointments across institutions.
    • Leads research programs in drug discovery, pharmacognosy, marine natural products, and biomedical sciences.
    • Founder and Chief Scientific Officer of Sycamore Biopharma and Oxford Laboratories.

Education 🎓

  • Postdoctoral Research (1993) – Marine Natural Products, McMurdo, Antarctica & University of Hawaii, Honolulu
  • Ph.D. in Organic Chemistry (1992) – University of Hawaii, under the guidance of Professor Emeritus Paul Scheuer
  • B.S. in Chemistry and Biology (1985) – Bemidji State University, Minnesota

Experience 🏛️

Dr. Hamann has held various prestigious academic and research positions, including:

  • Professor of Drug Discovery & Biomedical Sciences, MUSC
  • Director of Clinical Studies, Branded Legacy, Inc. (2024–Present)
  • Cofounder & CSO, Sycamore Biopharma & Oxford Laboratories (acquired by Branded Legacy in 2024)
  • Joint Appointed Professor, Clemson-MUSC Biomedical Data Sciences & Informatics Program
  • Adjunct Professor, College of Charleston & University of Maryland Center for Environmental Science
  • Principal Investigator, Bigelow Marine Laboratory

His work spans pharmacology, marine biotechnology, and biomedical sciences, focusing on translational research from lab discoveries to clinical applications.

Research Interests On Toxicology 🔬

Dr. Hamann’s research revolves around:

  • Marine Natural Products – Identifying bioactive compounds from marine organisms for therapeutic use.
  • Cancer Therapeutics – Developing novel anticancer agents, particularly targeting drug-resistant tumors.
  • Infectious Diseases & COVID-19 Research – Investigating antiviral compounds, including inhibitors for SARS-CoV-2.
  • Biomedical Informatics & AI in Drug Discovery – Harnessing computational tools for accelerating pharmaceutical innovation.

Awards & Honors 🏆

Dr. Hamann has received numerous accolades, including:

  • Presidential Candidate Nomination, American Society of Pharmacognosy (2024/2025)
  • MUSC College of Pharmacy Researcher of the Year (2024)
  • Stanford-PLOS One Report – Ranked in the top 1% of scientists globally
  • Lifetime Membership Award, International Marine Biotechnology Association (2020)
  • Best Publication of the Year (2021) – Journal of Antibiotics, Nature Publishing
  • Chair & Member of NIH, NCCIH, and NIDA Study Sections (2020-2024)

Publications 📚

  1. Marine indole alkaloids: potential new drug leads for the control of depression and anxiety
    • Authors: AJ Kochanowska-Karamyan, MT Hamann
    • Year: 2010
    • Citations: 2001
  2. Lamellarins and related pyrrole-derived alkaloids from marine organisms
    • Authors: H Fan, J Peng, MT Hamann, JF Hu
    • Year: 2008
    • Citations: 1159
  3. Marine natural products and their potential applications as anti-infective agents
    • Authors: M Donia, MT Hamann
    • Year: 2003
    • Citations: 736
  4. Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases
    • Authors: W Gul, MT Hamann
    • Year: 2005
    • Citations: 538
  5. Marine natural products as novel antioxidant prototypes
    • Authors: S Takamatsu, TW Hodges, I Rajbhandari, WH Gerwick, MT Hamann, …
    • Year: 2003
    • Citations: 364
  6. Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis …
    • Authors: AMS Mayer, AD RodrĂ­guez, RGS Berlinck, MT Hamann
    • Year: 2009
    • Citations: 354
  7. Kahalalide F: a bioactive depsipeptide from the sacoglossan mollusk Elysia rufescens and the green alga Bryopsis sp
    • Authors: MT Hamann, PJ Scheuer
    • Year: 1993
    • Citations: 353
  8. Marine pharmacology in 2001–2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet …
    • Authors: AMS Mayer, MT Hamann
    • Year: 2005
    • Citations: 345
  9. Kahalalides:  Bioactive Peptides from a Marine Mollusk Elysia rufescens and Its Algal Diet Bryopsis sp.
    • Authors: MT Hamann, CS Otto, PJ Scheuer, DC Dunbar
    • Year: 1996
    • Citations: 336
  10. In vivo antimalarial activity of the beta-carboline alkaloid manzamine A
  • Authors: KKH Ang, MJ Holmes, T Higa, MT Hamann, UAK Kara
  • Year: 2000
  • Citations: 315

Conclusion 🌍

Dr. Mark T. Hamann is a pioneering scientist whose work has had a lasting impact on drug discovery, cancer therapeutics, and marine natural products research. His dedication to translational science and mentorship continues to shape the future of pharmaceutical innovations.

Donato Antonio Raele | Forensic science | Best Researchrer Award

Dr. Donato Antonio Raele | Forensic science | Best Researcher Award

Veterinary manager| Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata| Italy

Dr. Donato Antonio Raele is an esteemed Veterinary Manager at the Experimental Zooprophylactic Institute of Puglia and Basilicata, where he oversees critical diagnostics and research efforts in the field of virology. A graduate of the University of Teramo with advanced specialization in veterinary infectious diseases, he has built an extensive career in virological diagnostics, particularly focusing on arboviruses and vector-pathogen interactions. Dr. Raele has led numerous research initiatives funded by the Italian Ministry of Health and actively contributes to national and European scientific projects. An active speaker and contributor to conferences, he has authored over 30 scientific works and is a peer reviewer for leading international journals. Notably, he discovered and named a new pathogenic bacterial species, Psychrobacter raele.

Profile

Google Scholar

Educational

Dr. Donato Antonio Raele holds a degree in Veterinary Medicine from the University of Teramo, earned in 2003. He pursued further specialization in veterinary infectious diseases, completing a three-year program in “Infectious Diseases, Prophylaxis, and Veterinary Police” at the University of Bari in 2013. He also holds two postgraduate qualifications: a Master’s in “Veterinary Interventions in Emergencies” from the University of Bari, completed in 2005, and a Master’s in “Animal-Assisted Interventions” from ASLFG, obtained in 2021.

Professional Experience

Dr. Raele is a Veterinary Manager at the Experimental Zooprophylactic Institute of Puglia and Basilicata (IZSPB), currently serving in the General and Special Virological Diagnostics department at the IZSPB branch in Foggia. Over his career, he has held roles such as Veterinary Manager for Area C of the Local Health Authority and as a Vet Researcher at IZSPB. Dr. Raele’s extensive professional experience spans a broad range of veterinary management and research responsibilities, particularly in the field of virological diagnostics and infectious diseases. He has led numerous research projects funded by the Ministry of Health, including his role as the Scientific Head for various IZSPB projects (RC IZSPB 06/22, RC IZSPB 01/21) and project manager. His research has contributed to important advancements in understanding arboviruses and vector-borne diseases, as well as their impacts on human, animal, and environmental health.

Research Interests

Dr. Raele’s primary research interests focus on the diagnosis and study of arboviruses, with a specific emphasis on the interactions between vectors and pathogens. His work addresses significant areas of veterinary virology, including the spread of vector-borne viruses and intracellular pathogens. His interdisciplinary approach links human, animal, and environmental health, making notable contributions to the study of zoonotic diseases and bioterrorism. Dr. Raele is also involved in operational units working on health and safety in emergency veterinary

Author Metrics

Dr. Raele has authored and co-authored more than 30 scientific papers presented at national and international conferences. His research is published in peer-reviewed international journals with Impact Factors, including Applied and Environmental Microbiology, Journal of Vector Borne Diseases, Scientific Reports, Pathogens, Microrganisms, and Gene. He serves as a peer reviewer for several high-impact journals indexed in PUBMed.

Publication

First report of Coxiella burnetii and Borrelia burgdorferi sensu lato in poultry red mites, Dermanyssus gallinae (Mesostigmata, Acari), related to urban outbreaks of dermatitis …

  • DA Raele, D Galante, N Pugliese, G La Salandra, M Lomuto, MA Cafiero
  • New Microbes and New Infections 23, 103-109

  Discrimination of Bacillus cereus Group Members by MALDI-TOF Mass Spectrometry

  • V Manzulli, V Rondinone, A Buchicchio, L Serrecchia, D Cipolletta, …
  • Microorganisms 9 (6), 1202

 Coxiella-like endosymbiont associated to the “Anatolian brown tick” Rhipicephalus bursa in Southern Italy

  • DA Raele, D Galante, N Pugliese, E De Simone, MA Cafiero
  • Microbes and Infection 17 (11-12), 799-805

 Detection of Coxiella burnetii DNA in sheep and goat milk and dairy products by droplet digital PCR in south Italy

  • MG Basanisi, G La Bella, G Nobili, DA Raele, MA Cafiero, R Coppola, …
  • International Journal of Food Microbiology 366, 109583

  Molecular detection of Coxiella burnetii using an alternative loop-mediated isothermal amplification assay (LAMP)

  • DA Raele, G Garofolo, D Galante, MA Cafiero
  • Vet Ital 51 (1), 73-78